EIGER BIOPHARMACEUTICALS INC (EIGR) Stock Earnings & Estimates
NASDAQ:EIGR - US28249U2042 - Common Stock
1.725 USD
-0.17 (-9.21%)
1.7 USD
-0.03 (-1.45%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.14M | 13.48M 11.04% | 15.773M 17.01% | 25.722M 63.08% | 33.307M 29.49% | 35.044M 5.22% | 36.874M 5.22% | 56.937M 54.41% | 165.05M 189.88% | 273.77M 65.87% | |
| EBITDA YoY % growth | -76.66M -23.69% | -92.45M -20.60% | -71.503M 22.66% | 5.161M 107.22% | -45.837M -988.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -76.94M -23.80% | -92.74M -20.54% | -71.778M 22.60% | -21.971M 69.39% | -6.345M 71.12% | -5.142M 18.97% | -4.205M 18.21% | 14.416M 442.79% | 117.53M 715.27% | 223.34M 90.03% | |
| Operating Margin | -633.77% | -687.98% | -455.07% | -85.42% | -19.05% | -14.67% | -11.40% | 25.32% | 71.21% | 81.58% | |
| EPS YoY % growth | -2.37 -2.60% | -18.87 -696.20% | N/A -165.95% | -15.91 68.29% | -3.67 76.92% | -0.10 97.22% | -0.09 10.00% | 0.12 233.33% | 1.34 991.67% | 2.52 88.55% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -5.51 64.69% | -3.98 71.79% | -3.67 70.15% | -2.75 64.00% |
| Revenue Q2Q % growth | 5.659M 37.42% | 6.173M 33.04% | 6.688M 108.35% | 7.202M 89.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.364M 66.90% | -5.25M 73.72% | -4.868M 71.24% | -4.487M 64.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 55.26% | -7.65 | % | |
| Q3 2023 Q2Q % growth | -12.30 -1,883.87% | -9.90 | -2.40 | -24.19% |
| Q2 2023 Q2Q % growth | -14.10 -2,664.71% | -12.55 | -1.55 | -12.39% |
| Q1 2023 Q2Q % growth | -15.60 -2,337.50% | -14.47 | -1.13 | -7.78% |
| Q4 2022 Q2Q % growth | -17.10 -2,571.88% | -16.63 | -0.47 | -2.80% |
| Q3 2022 Q2Q % growth | -0.62 4.62% | -0.53 | -0.09 | -16.58% |
| Q2 2022 Q2Q % growth | -0.51 10.53% | -0.62 | 0.11 | 17.56% |
| Q1 2022 Q2Q % growth | -0.64 -25.49% | -0.66 | 0.02 | 2.46% |
| Q4 2021 Q2Q % growth | -0.64 -12.28% | -0.65 | 0.01 | 1.93% |
| Q3 2021 Q2Q % growth | -0.65 -25.00% | -0.57 | -0.08 | -13.59% |
| Q2 2021 Q2Q % growth | -0.57 5.00% | -0.56 | -0.01 | -2.13% |
| Q1 2021 Q2Q % growth | -0.51 17.74% | -0.02 | -0.49 | -2,018.64% |
| Q4 2020 Q2Q % growth | -0.57 16.18% | 0.26 | -0.83 | -321.03% |
| Q3 2020 Q2Q % growth | -0.52 31.58% | -0.60 | 0.08 | 13.30% |
| Q2 2020 Q2Q % growth | -0.60 20.00% | -0.73 | 0.13 | 17.54% |
| Q1 2020 Q2Q % growth | -0.62 31.11% | -0.82 | 0.20 | 24.27% |
| Q4 2019 Q2Q % growth | -0.68 | -0.44 | -0.24 | -54.92% |
| Q3 2019 Q2Q % growth | -0.76 | -0.76 | 0.00 | 0.39% |
| Q2 2019 Q2Q % growth | -0.75 | -0.76 | 0.01 | 1.15% |
| Q1 2019 Q2Q % growth | -0.90 | -0.97 | 0.07 | 7.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 3.803M 40.85% | 6.609M | -2.806M | -42.46% |
| Q3 2023 Q2Q % growth | 3.21M -20.15% | 5.014M | -1.804M | -35.98% |
| Q2 2023 Q2Q % growth | 4.64M 13.45% | 4.66M | -20K | -0.43% |
| Q1 2023 Q2Q % growth | 4.118M 54.23% | 4.244M | -126K | -2.97% |
| Q4 2022 Q2Q % growth | 2.7M -19.64% | 4.523M | -1.823M | -40.31% |
| Q3 2022 Q2Q % growth | 4.02M 32.24% | 4.356M | -336K | -7.71% |
| Q2 2022 Q2Q % growth | 4.09M 94.76% | 4.775M | -685K | -14.35% |
| Q1 2022 Q2Q % growth | 2.67M -26.85% | 4.118M | -1.448M | -35.16% |
| Q4 2021 Q2Q % growth | 3.36M | 3.411M | -51K | -1.50% |
| Q3 2021 Q2Q % growth | 3.04M | 2.996M | 44K | 1.47% |
| Q2 2021 Q2Q % growth | 2.1M | 2.197M | -97K | -4.42% |
| Q1 2021 Q2Q % growth | 3.65M | 13.265M | -9.615M | -72.48% |
| Q4 2020 Q2Q % growth | 24.251M | -24.251M | -100.00% | |
| Q3 2020 Q2Q % growth | 1.632M | -1.632M | -100.00% | |
| Q1 2020 Q2Q % growth | 637.5K | -637.5K | -100.00% | |
| Q4 2019 Q2Q % growth | 631.635K | -631.635K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -159.02% | 0% | -2900% |
| Revenue | 0% | 0% | 0% | 0% |